The clinical role of probiotic and prebiotic supplementations during and after maternal gestation

Background: For over two decades we have been trying to study and demonstrate the role of the gut microbiota in the onset of cardiovascular, autoimmune, infectious and neurobiological diseases, and more generally the clinical efficacy.  Materials and methods: All clinical trials and randomized contr...

Full description

Saved in:
Bibliographic Details
Main Author: Giulio Perrotta (Author)
Format: Book
Published: Hygeia Press di Corridori Marinella, 2023-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_ee185e6772484539ad0ab35423ce1b06
042 |a dc 
100 1 0 |a Giulio Perrotta  |e author 
245 0 0 |a The clinical role of probiotic and prebiotic supplementations during and after maternal gestation 
260 |b Hygeia Press di Corridori Marinella,   |c 2023-09-01T00:00:00Z. 
500 |a 2281-0692 
500 |a 10.7363/120203 
520 |a Background: For over two decades we have been trying to study and demonstrate the role of the gut microbiota in the onset of cardiovascular, autoimmune, infectious and neurobiological diseases, and more generally the clinical efficacy.  Materials and methods: All clinical trials and randomized controlled trials were selected up to March 30, 2023, for a useful total of 45 studies.  Results: Significant evidence emerges in the literature that supports the therapeutic use for clinical purposes of prebiotics and probiotics even during gestation and within the first 2 years of life, of specific bacterial strains of Lactobacillus and Bifidobacterium (with almost no definite evidence for S. boulardii) to promote proper intestinal eubiosis, slow down inflammatory and infectious processes, including those of an allergic nature, and prevent or ameliorate disease states such as that of gestational diabetes mellitus, sepsis, necrosis, and preeclampsia. In addition, the use of high-fat polyunsaturated fatty acid (HF-PUFA) blends from fish oil, fermented milk supplemented with probiotic strains, and galactooligosaccharides/polydextrose (GOS/PDX) seems useful.  Conclusions: There emerges, therefore, the need, in such a varied and contradictory landscape, to design a research project that takes into account, first of all, a significant and representative population sample, but above all, one that does not underestimate the critical issues mentioned above, to address with a scientific method the proper and functional use of prebiotics and probiotics in the neonatal and obstetrical fields in general; further studies that can confirm and expand scientific knowledge in this particular field are therefore needed. 
546 |a EN 
546 |a IT 
690 |a premature infants 
690 |a probiotics 
690 |a prebiotics 
690 |a maternal gestation 
690 |a pregnancy 
690 |a Medicine 
690 |a R 
690 |a Pediatrics 
690 |a RJ1-570 
655 7 |a article  |2 local 
786 0 |n Journal of Pediatric and Neonatal Individualized Medicine, Vol 12, Iss 2, Pp e120203-e120203 (2023) 
787 0 |n https://jpnim.com/index.php/jpnim/article/view/1567 
787 0 |n https://doaj.org/toc/2281-0692 
856 4 1 |u https://doaj.org/article/ee185e6772484539ad0ab35423ce1b06  |z Connect to this object online.